Daily non-political popular news in brief.

U of S Vaccine and Infectious Disease Organization team discovers key step in flu virus replication

As public health officials around the world keep a nervous eye on the spread of avian influenza, the University of Saskatchewan's Vaccine and Infectious Disease Organization has uncovered a key step in how the influenza virus causes infection.

Read more »

Keywords: vaccine, infectious, disease, organization, team, discovers, key, step, flu, virus, replication, infectiou, discover, viru

« Previous | Next »

Similar news on "U of S Vaccine and Infectious Disease Organization team discovers key step in flu virus replication":

1. Researchers discover key mechanism by which lethal viruses Ebola and Marburg cause disease
   10-16-2006 · EurekAlert!
   Researchers in the Greene Infectious Disease Laboratory at Columbia University's Mailman School of Public Health, the Centers for Disease Control and Prevention, and the Caribbean Primate Research Center have discovered a key mechanism by which the Filoviruses, Ebola and Marburg, cause disease.
   Similar news · Read more »
   
2. In-shell vaccine for chick disease
   01-04-2007 · EurekAlert!
   Infectious bronchitis virus causes devastating losses to the poultry industry but scientists are now developing a new way to vaccinate chicks against the disease -- one that can be delivered while they are still in their egg. Researchers have used a "reverse genetic" system to produce a new vaccine strain which is safe to deliver to chicks while they are still in the egg, making it more effective than current vaccines.
   Similar news · Read more »
   
3. Pneumococcal conjugate vaccines can improve the lives of HIV-infected children
   11-28-2007 · EurekAlert!
   An international team of experts has published the first comprehensive review of evidence on pneumococcal conjugate vaccination for children with HIV infection. Now available in the online edition of the journal Lancet Infectious Diseases, the review shows that HIV increases the risk of pneumococcal infection by up to 40 fold, that the disease is usually due to serotypes in the PCV, and that the vaccine can protect HIV-infected infants.
   Similar news · Read more »
   
4. Scientists unveil piece of HIV protein that may be key to AIDS vaccine development
   02-14-2007 · EurekAlert!
   In a finding that could have profound implications for AIDS vaccine design, researchers led by a team at the NIAID have generated an atomic-level picture of a key portion of an HIV surface protein as it looks when bound to an infection-fighting antibody. Unlike much of the constantly mutating virus, this protein component is stable and -- more importantly, say the researchers -- appears vulnerable to attack from this specific antibody, known as b12, that can broadly neutralize HIV.
   Similar news · Read more »
   
5. Smallpox vaccine alternative identified
   01-07-2008 · EurekAlert!
   University of California, Irvine infectious disease researchers have shown the effectiveness of a potential alternative to the existing smallpox vaccine that can replace the current biodefense stockpile for this lethal virus.
   Similar news · Read more »
   
6. Study confirms limited human-to-human spread of avian-flu virus in Indonesia in 2006
   08-28-2007 · EurekAlert!
   In the first systematic, statistical analysis of its kind, infectious disease modeling experts at Fred Hutchinson Cancer Research Center confirm that the avian influenza A (H5N1) virus in 2006 spread between a small number of people within a family in Indonesia.
   Similar news · Read more »
   
7. Avian influenza survivors' antibodies effective at neutralising H5N1 strain
   05-28-2007 · EurekAlert!
   Adults who have recovered from the potentially deadly H5N1 strain of avian influenza may hold the key to future treatments for the virus, according to an international team of researchers. In a study published today in the open access journal PLoS Medicine, the researchers have shown how specific antibodies taken from avian flu survivors in Vietnam can be reproduced in the laboratory and prove effective at neutralising the virus in culture vitro and in mice.
   Similar news · Read more »
   
8. First genome-wide study of infectious disease opens new avenues for HIV treatment, vaccines
   07-19-2007 · EurekAlert!
   The first genome-wide association study of an infectious disease, conducted by an international group of researchers through the Center for HIV/AIDS Vaccine Immunology, has yielded a new understanding of why some people can suppress virus levels following HIV infection. "The clearer picture of host responses to the virus achieved through this examination of genomes could lead to improved HIV therapies and provides new targets for vaccine developers," says Elias A. Zerhouni, M.D., director of the National Institutes of Health.
   Similar news · Read more »
   
9. Human antibodies protect mice from avian flu
   05-28-2007 · EurekAlert!
   An international team of scientists, including researchers from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, report using antibodies derived from immune cells from recent human survivors of H5N1 avian influenza to successfully treat H5N1-infected mice as well as protect them from an otherwise lethal dose of the virus.
   Similar news · Read more »
   
10. Scientists discover new virus caused deaths of transplant recipients from single donor
    04-23-2007 · EurekAlert!
    Scientists in the Greene Infectious Disease Laboratory of the Columbia University Mailman School of Public Health and colleagues in the Victorian Infectious Diseases Reference Laboratory in Melbourne, Australia and 454 Life Sciences have discovered a new virus that was responsible for the deaths of three transplant recipients who received organs from a single donor in Victoria, Australia.
    Similar news · Read more »